$41 SEGO 100% Remy Human Hair Toppers with Bangs for Women Silk Base Beauty Personal Care Hair Care Hair Extensions, Wigs Accessor Hair,/invertend1728475.html,Bangs,Women,SEGO,Remy,Beauty Personal Care , Hair Care , Hair Extensions, Wigs Accessor,Silk,Human,100%,for,Base,$41,katzesuchtkater.de,Toppers,with Hair,/invertend1728475.html,Bangs,Women,SEGO,Remy,Beauty Personal Care , Hair Care , Hair Extensions, Wigs Accessor,Silk,Human,100%,for,Base,$41,katzesuchtkater.de,Toppers,with $41 SEGO 100% Remy Human Hair Toppers with Bangs for Women Silk Base Beauty Personal Care Hair Care Hair Extensions, Wigs Accessor SEGO 100% Remy Human Hair Toppers 1 year warranty Silk Bangs Base Women with for SEGO 100% Remy Human Hair Toppers 1 year warranty Silk Bangs Base Women with for

SEGO 100% Remy Human Hair Toppers 1 OFFicial store year warranty Silk Bangs Base Women with for

SEGO 100% Remy Human Hair Toppers with Bangs for Women Silk Base

$41

SEGO 100% Remy Human Hair Toppers with Bangs for Women Silk Base

|||

Product Description

SEGO have been collecting customer feedback on our hair topper, and are committed to making a hair topper that can more satisfy the needs of the masses. Compared with other hair extensions, hair toppers have higher requirements for color matching, and different hair loss levels require different products.

Therefore, we often face that some customers will like our products very much, and some customers will not like our products. But it is also because of these good and bad reviews that encourage us to retain the advantages of the products, get rid of the shortcomings of the products, and continuously improve our quality.

22

This silk base hair topper is our newly developed product, with bangs and without bangs. If you are just choosing a suitable hair topper, you might as well try this one. If you like it very much, please leave your feelings under the comments. If you don’t like it, please tell us your dissatisfaction first, so that we have a chance to correct it, thank you.

11

Two Style

  1. Hair Topper With Bangs: suitable for top and frontal coverage ,and for those who want to modify the shape of the face.
  2. Hair Topper Without Bangs: mainly cover the top and side,less focus on backside.

The stages of hair loss can be classified by the amount of hair that you have lost.There are 3 stages of hair loss:

Beginning-small base

Progressive-medium or large base

Advanced-largest base or full wig、

NOTICE:

This hair topper is suitable for the people at the beginning and middle stage of hair loss, not suitable for the severe one, because it needs hair to clip.

11

Notice Before Order:

  • About Color: All pictures are taken by ourselves, but considering light and different monitor, the exact color might be slightly different from the picture showed.
  • About Style: Our remy human hair topper just like your own hair and can be styled, cutted, curled or straightened asdesired.
  • About Odour:Product may remain a bit chemical smelling after processing.If it does,soak it with fragrant conditioner for a while and the odour will disappear.
  • About Product Problem: If you have any problems with the product, please give us a chance to help you, we will try our best to work it out.
1 2 3 4 5 6
150% Density Silk Base Hair Topper with Bangs 150% Density Silk Base Hair Topper 120% Density Silk Base Hair Topper 130% Density Silk Base Hair Topper with Bangs 150% Density Mono Base Hair Topper with Bangs Synthetic Hair Topper with Bangs
Hair Material: 100% real human hair 100% real human hair 100% real human hair 100% real human hair 100% real human hair high-quality synthetic fibers
Base Size: 13cm*7cm 13cm*7cm 12cm *10cm 12cm *10cm 10cm *10cm 7cm*5cm
Hair Density: 150% Density 150% Density 120% Density 130% Density 150% Density 120% Density
Hair Bangs: with bangs no bangs no bangs with bangs with bangs with bangs
Hair Size: 6inch/10inch/12inch/14inch/16inch/18inch 6inch/10inch/12inch/14inch 6inch/10inch/12inch/14inch/16inch/18inch 6inch/10inch/12inch/14inch 10inch/12inch/ 14inch 10inch

SEGO 100% Remy Human Hair Toppers with Bangs for Women Silk Base

CURRENT ISSUE
November, 2021

No. 106 (11)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma

Transducin β-like protein 1 (TBL1) plays a crucial role in controlling the stability of regulatory proteins involved in cell proliferation and autophagy induction. This study revealed that, unlike normal B cells, diffuse large B-cell lymphoma cells express abundant levels of TBL1 and its overexpression correlates with poor clinical outcome. Targeting TBL1 promoted lymphoma cell death in vitro and in vivo. These results provide the rationale for targeting TBL1 as a novel therapeutic strategy in diffuse large B-cell lymphoma.

Youssef Youssef et al.

Article

Targeting shear gradient activated von Willebrand factor by the novel single-chain antibody A1 reduces occlusive thrombus formation in vitro

The authors of this study developed a single-chain antibody that targets a shear gradient-specific conformation of von Willebrnad factor (VWF). In vitro studies showed that this antibody specifically reduces VWF-GPIbα binding and thrombus formation at sites of shear rate gradients but does not block platelet deposition and aggregation under constant shear rate. This characteristic places the antibody in a new class of antiplatelet therapy for selective blockade of pathological thrombus formation while maintaining normal hemostasis.

Thomas Hoefer et al.

Case Report

Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia

A 26-year-old female developed vaccine-induced immune thrombotic thrombocytopenia (VITT) with cerebral venous thrombosis and bi-hemispheric hemorrhage following the first dose of the ChAdOx1 nCoV-19 vaccine. The treatment protocol, based on intravenous immunoglobulins, dexamethasone and argatroban was successful with almost complete clinical, laboratory and radiological response. This experience supports the application of an early and multidisciplinary therapeutic approach in cases of VITT, with the possibility of avoiding deaths and obtain a resolution of the syndrome.

Sara Bonato et al.

Letter

Allogeneic hematopoietic stem cell transplantation from non-sibling 10/10 HLA-matched related donors: a single-center experience

This retrospective study compared the outcome of allogeneic hematopoietic stem cell transplantation (HSCT) in 23 patients with hematologic malignancies transplanted from non-sibling fully matched related donors to that of patients who underwent conventional haplo-HSCT. Subjects transplanted from fully matched related donors showed trends to a higher relapse rate and lower cumulative incidence of grade II-IV acute graft-versus-host disease, but overall survival was similar. The authors concluded that individualized adjustment of the immunosuppressive treatment is reasonable for this category of patients.

Yaoyao Shen et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA